In 2020, North America accounted for the largest share of the nuclear medicine market. North America to witness significant growth from 2021 to 2026
The high growth of this segment can be attributed to the increasing incidence and prevalence of thyroid disorders The thyroid applications segment is projected to register the highest growth rate in the forecast period. The SPECT applications is further segmented into cardiology, bone scans, thyroid applications, pulmonary scans, and other SPECT applications. Thyroid applications segment is expected to register the highest growth during the forecast periodīased on application, the nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The large share of this segment can be attributed to the non-invasiveness, increasing prevalence of cardiovascular diseases and early diagnosis. The diagnostic segment accounted for a larger share of the market 2020. On the basis of type, the nuclear medicine market is segmented into diagnostic and therapeutic.
Therapeutic segment is expected to grow at the highest CAGR
0 kommentar(er)
